Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-24-038470

Director sold 23,000 shares at $3.57 ($82,110)

  • Director acquired 23,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Patrick Kristin · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-23 Exercise or conversion : show line 1 in the form +3,000 $1.64 $4,920 3,000 D
2024-08-23 Exercise or conversion : show line 2 in the form +20,000 $1.67 $33,400 23,000 D
2024-08-23 Sale : show line 3 in the form −23,000 $3.57 $82,110 0 D
Open-market sales · 23,000 sh · avg $3.57 · $82,110

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-08-23 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −3,000 17,000 D
2024-08-23 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −20,000 0 D
Loading xslF345X05/wk-form4_1724713582.xml…